General
Bio-Rad Launches Validated Antibodies for Rare Cell and Circulating Tumor Cell Enumeration
News
Filter:
General
Ubiquigent and Debiopharm Enter Agreement to Support USP1 Inhibitor Programme for Debio 0432
General
Empowering innovation: Cancer Research Horizons recognises trailblazers in oncology
General
Evgen Pharma – Acquisition, Fundraising and Change of Name
General
Highly consistent collagen fibre scaffold for 3D cell culture
General
CryoLogyx Completes £500k Seed Funding Round
General
FemTech and Women’s Health start-ups urged to join Discovery Park’s growth programme, offering...
General
Green nano-technology company Nium relocates R&D to Milton Park
General
Exploristics and Exonate announce successful collaboration to enhance clinical trial study desi...
General
Ubiquigent enters agreement with Astellas subsidiary, Nanna Therapeutics
General
Exonate first-in-class eye drop Phase Ib/IIa trial data demonstrate safety and biological activ...
General
Products and Services for Diversifying Preclinical Models